Scholar Rock
@ScholarRock
Followers
580
Following
43
Statuses
487
Biopharma leader in the biology of the #TGFbeta superfamily of protein growth factors. Community Guidelines: https://t.co/VU9mLWhf59
Cambridge, MA, USA
Joined April 2015
Scholar Rock's innovative pipeline is driven by our unique insights into transforming growth factor-beta (TGFβ) biology. Visit our new website to learn more:
0
0
2
Scholar Rock is a proud sponsor of the 2nd Annual Summit of Strength & Walk-n-Roll in Puerto Rico to raise awareness of SMA and empower those affected. Through our science, we’re committed to #CreatingPossibilities for the #SMA community.
0
0
2
We are pleased to announce the submission of our Biologics License Application (BLA) to the U.S. FDA for our investigational treatment in SMA. As we await next steps, we're proud of the teamwork & mission focus that brought us to this stage. Read more:
0
3
11
2025 will be a pivotal year for Scholar Rock. As we work with urgency to advance our mission, we remain unwavering in our commitment to patients. Learn more:
0
0
3
The Scholar Rock team will be presenting today at the 43rd Annual J.P. Morgan Healthcare Conference on our priorities and pipeline in 2025 and beyond. Webcast details can be found on our website:
0
0
3
We're thrilled that our new website is now live! Learn about Scholar Rock, the science driving our innovative pipeline, and the stories that drive us every day in our work to create possibilities for patients.
0
0
2
Scholar Rock recently announced key priorities for 2025 as we work towards advancing our clinical programs and #AcceleratingBreakthroughs for patients. Read more:
0
0
1
As 2025 kicks off, stay tuned for our new Scholar Rock website. We’re excited to soon launch this new channel for updates, perspectives and stories centered around our mission of #CreatingPossibilities.
0
0
2
Happy New Year! Scholar Rock will be presenting at #JPM25 on Tuesday, January 14, at 9:45 a.m. PST. For more information and a link to the live webcast, please visit our website:
0
1
2
The past year was a transformative one for Scholar Rock, as we worked to advance milestones along our journey to create new possibilities for patients. Check out some of our highlights from 2024:
0
0
1
We’re proud to see Scholar Rock’s own Jay Backstrom, and our scientific innovation, recognized as a standout in @adamfeuerstein's recent column. Read more:
0
0
1
We’re excited to soon launch our new Scholar Rock website, coming in 2025. Here’s a sneak peek of what you can expect:
0
0
0
Wishing everyone a wonderful Thanksgiving! We’re thankful for our brilliant Scholar Rockers. Your commitment to #CreatingPossibilities for people living with serious diseases helps us advance our mission to deliver potentially life-changing therapies to patients in need.
0
0
0
Tomorrow at #SITC2024, we will share clinical & biomarker updates from our Ph1 DRAGON trial evaluating SRK-181, our investigational candidate being studied to overcome primary resistance to checkpoint inhibitor therapy, such as anti-PD-(L)1 antibodies.
0
0
3
Today our colleague Melissa Fulham will present new preclinical data on SRK-439, our investigational myostatin inhibitor for the treatment of cardiometabolic disorders including obesity at the @ObesitySociety’s #OW2024. Learn more:
0
0
1
This #NationalFamilyCaregiversMonth, we recognize family members and caregivers, like Kim, who support individuals living with #SMA. Like you, we work every day to create new possibilities and drive the best outcomes for patients and families.
0
0
2
Inspiring stories like Annie’s demonstrate the passion and determination of the #SMA community – and they affirm our commitment to championing what matters most for patients and families.
0
0
3
The positive topline results from our Ph3 SAPPHIRE trial mark a major milestone for Scholar Rock and wouldn’t have been possible without our employees’ commitment to our mission of #CreatingPossibilities for patients.
0
2
5
This afternoon, Scholar Rock will present baseline characteristics from our Phase 3 SAPPHIRE trial of our investigational treatment for SMA, at the 29th Annual Congress of the @WorldMuscleSoc. Read more: #WMS2024
0
0
5